ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 45 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -14.3% | 6,000 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | +16.7% | 6,000 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | -14.3% | 6,000 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +16.7% | 6,000 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -99.7% | 6,000 | -99.7% | 0.00% | -100.0% |
| Q4 2019 | $2,289,000 | +38050.0% | 2,001,000 | +33250.0% | 0.00% | – |
| Q1 2018 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | -25.0% | 6,000 | -25.0% | 0.00% | – |
| Q3 2017 | $8,000 | +33.3% | 8,000 | +33.3% | 0.00% | – |
| Q2 2017 | $6,000 | +200.0% | 6,000 | +200.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 16,935,000 | $17,946,697,000 | 3.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,700,000 | $48,504,000 | 2.18% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $21,312,000 | 1.66% |
| LINDEN ADVISORS LP | 34,494,000 | $36,562,000 | 1.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 96,239,000 | $101,731,000 | 1.13% |
| MACKAY SHIELDS LLC | 24,155,000 | $25,567,000 | 0.95% |
| Verition Fund Management LLC | 10,200,000 | $10,799,000 | 0.87% |
| Jabre Capital Partners S.A. | 4,000,000 | $4,243,000 | 0.82% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 38,030,000 | $40,330,000 | 0.76% |
| AQR Arbitrage LLC | 44,600,000 | $47,220,000 | 0.51% |